Session I |
: |
|
|
|
|
Opening Remarks |
: |
Jawed Fareed, President, SASAT |
|
|
|
Plenary Lectures |
|
|
Chair |
: |
Dr. Fareed and Gundu H. R. Rao |
|
|
|
09:00-09:50am |
: |
Keynote Address "Historic Perspective on Heparins"
Sir Vijay Kakkar MD, FRCS |
|
|
|
09:50-10:00am |
: |
Newer Oral Anticoagulant Drugs and Their Impact on the Management of
Thrombosis
Alexander G.G. Turpie, M.D. |
|
|
|
10:00-10:30am |
: |
Coffee Break |
|
|
|
Session II |
|
|
Chairs |
: |
Dr. V Prakash and Prof. VV Kakkar |
|
|
Special Lectures on Atherosclerosis and Thrombosis |
|
|
|
10:30-10:50am |
: |
CVDs: Indian Perspective
Sridahr Dwivedi M.D Ph.D |
|
|
|
10:50- 11:10am |
: |
Diagnosis of Pre Clinic Arthrosclerosis: Myth and Reality
Ravi Kasliwal M.D. |
|
|
|
11:10-11:30am |
: |
Management of Metabolic Disorders with Statins
Dipti Itchhaponaria, MD |
|
|
|
11:30-11:50am |
: |
Newer anti-thrombotic Therapies. Are Unmet Needs Met!
Jawed Fareed, Ph.D |
|
|
|
12:00-01:00pm |
: |
Lunch |
|
|
|
Session III |
: |
Guest Lectures |
Chairs |
: |
Dr. Kasliwal and Dr. U. N. Das |
|
|
|
|
|
Cardio-Metabolic Disorders |
|
|
|
01:00-01:20pm |
: |
Metabolic syndrome in the young.
Usha Sriram M.D. |
|
|
|
01:20-01:40pm |
: |
Cardio-Metabolic Risk Factors in Mysore; findings from retrospective and
prospective ??Birth Cohort Studies"
Veena SR, M.D and Krishnaveni, M.D. |
|
|
|
01:40-02:00pm |
: |
Inflammation in Cardio-metabolic Syndrome: How to weather the perfect storm
Kris Vijay M.D. |
|
|
|
02:00-02:20pm |
: |
Do we need tight control of blood glucose? Overview.
U. N. Das, M.D. |
|
|
|
02:20-02:40pm |
: |
Prevalence of CVD and Diabetes in Urban and Rural Kolar
BG Ranganath, M.D. |
|
|
|
02:40-03:00pm |
: |
Panel Discussion on Cardio-Metabolic Disorders |
|
|
|
03:00-03:15pm |
: |
Coffee Break |
|
|
|
Session IV |
: |
Invited Lectures |
Chairs |
: |
Kris Vijay and Dr. Krishna Swamy |
|
|
|
03:20-03:40pm |
: |
The Chemistry and Biology of AGE and RAGE in Diabetes
P.R. Krishna Swamy, Ph.D |
|
|
|
03:40-04:00pm |
: |
"Changes in laminin in kidney during diabetes and its binding to
extra-cellular membrane constituents and modulation by dietary fiber and butyric
acid"
P. Salimath, Ph.D |
|
|
|
04:15-04:30pm |
: |
Prediction of risk to microvascular complications in Type 2 Diabetes using
co-expression network biology models
Shipra Agrawal, Ph.D |
|
|
|
04:15-04:30pm |
: |
"Thrombophilia in unprovoked DVT - Our experience"
Dr. K.R. Girija, JIVAS, Bangalore |
|
|
|
04:45-05:00pm |
: |
"Novel modalities of measuring atherosclerosis"
R. Ravikumar, Ph.D, Director - Thambiran Heart and Vascular Institute,
Chennai |
|
|
|
05:00-05:15pm |
: |
"Refractory Angina - New treatment options; Our experience"
Dr. Srikanth, M.D., Chennai |
|
|
|
05:15-05:30pm |
: |
"Role of C-Peptide in the Progress of Metabolic Syndrome among the type - 2 DM Individuals in South India".
Shaheena Banu, M.D., Ph.D., Head of the Department, Biochemistry, Sri
Jayadeva Institute of Cardiology, Bangalore |
|
|
|
05:45-06:00pm |
: |
"Concluding Remarks and Vote of Thanks:"
Gundu Rao, CEO, Jawed Fareed, President, and G. Muralidharan, COO |
|
|
|
08:00 pm onwards |
: |
Dinner for Faculty and Participants Sponsored by Medifil. |